[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570300":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":19,"locations":30,"responsibleParty":46,"collaborators":18,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":18,"enrollmentInfo":58,"targetDuration":18,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":74,"whyStopped":18,"lastUpdateSubmitDate":75,"lastUpdatePostDateStruct":76,"startDateStruct":79,"completionDateStruct":81,"leadSponsor":83,"locationsCount":84},{"fullName":5,"class":6},"CHU de Reims","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patients with unruptured and untreated aneurysms","EXPERIMENTAL","Patients in radiology for the first diagnostic evaluation or the follow-up of unruptured and untreated aneurysms.",[13],"Other: Additional 4D Flow MRI or additional 4D Flow sequence",[15],{"type":6,"name":16,"description":16,"armGroupLabels":17,"otherNames":18},"Additional 4D Flow MRI or additional 4D Flow sequence",[9],null,[20,26],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},"Sébastien SOIZE","CONTACT","03 10 73 62 17","0033","ssoize@chu-reims.fr",{"name":27,"role":22,"phone":28,"phoneExt":24,"email":29},"Christophe PORTEFAIX","03 26 78 94 82","cportefaix@chu-reims.fr",[31],{"facility":32,"status":18,"city":33,"state":18,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Damien JOLLY","Reims","51100","France","FR",{"type":38,"coordinates":39},"Point",[40,41],4.02853,49.26526,{"lat":41,"lon":40},[44,45],{"name":21,"role":22,"phone":23,"phoneExt":24,"email":25},{"name":27,"role":22,"phone":28,"phoneExt":18,"email":29},{"type":47,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100570300","mri-analysis-in-the-growth-of-cerebral-aneurysms-100570300",false,"NCT06705452","MRI Analysis in the Growth of Cerebral Aneurysms","4D-MRI Morphological Study of Local Growth in Cerebral Aneurysms","EPICAVC","inclusion criteria:\n\n* Patients with one or more unruptured intracranial aneurysms followed up at the participating center. Patients may have other ruptured and\u002For treated aneurysms\n* Patient older than 18 years\n* Patient consenting to participate to the study\n* Patient enrolled in the national healthcare insurance program\n\nexclusion criteria:\n\n* Patients who have already received surgical or endovascular treatment for all their aneurysm(s), or who are due to receive such treatment in less than 2 months.\n* Patients with only ruptured aneurysm(s)\n* Patients with arteriovenous malformations (treated or untreated)\n* Patients with a contraindication to MRI\n* Patients with an allergy to one of the contrast agents (Iodixanol, Gadoteric acid)\n* Pregnant or breast-feeding patients\n* Patients protected by law.","ALL","18 Years",{"count":59,"type":60},281,"ESTIMATED","INTERVENTIONAL",[63],"NA","An intracranial aneurysm is defined as a localized dilatation of the cerebral arteries, which can potentially lead to rupture and subsequent hemorrhagic stroke. The mechanisms by which aneurysms develop and grow remain unknown. The objective of this project is to utilize MRI, a routine non-invasive examination for detecting and following up aneurysms, to identify visually and quantitatively an aneurysm growth and relevant biomarkers that can predict the risk of aneurysm development.",[66],"Unruptured Intracranial Aneurysm",[68,69,70,71,72,73],"Aneurysm Growth","Unruptured Intracranial aneurysm","Cerebral Aneurysm","Vascular Diseases","Intracranial Arterial Diseases","Intracranial Aneurysm","NOT_YET_RECRUITING","2024-11-22",{"date":77,"type":78},"2024-11-26","ACTUAL",{"date":80,"type":60},"2025-01-01",{"date":82,"type":60},"2032-01-01",{"name":5,"class":6},1]